Cargando…
P1168: CHARACTERISTICS PREDICTIVE OF PROGRESSION DURING FRONTLINE TREATMENT IN AGGRESSIVE B-CELL LYMPHOMAS
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430099/ http://dx.doi.org/10.1097/01.HS9.0000847536.55944.b5 |
| _version_ | 1784779656707178496 |
|---|---|
| author | Bock, A. Mwangi, R. Maurer, M. Cerhan, J. Ng, W. L. King, R. Bennani, N. N. Ansell, S. Habermann, T. Witzig, T. Wang, Y. Nowakowski, G. |
| author_facet | Bock, A. Mwangi, R. Maurer, M. Cerhan, J. Ng, W. L. King, R. Bennani, N. N. Ansell, S. Habermann, T. Witzig, T. Wang, Y. Nowakowski, G. |
| author_sort | Bock, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430099 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94300992022-08-31 P1168: CHARACTERISTICS PREDICTIVE OF PROGRESSION DURING FRONTLINE TREATMENT IN AGGRESSIVE B-CELL LYMPHOMAS Bock, A. Mwangi, R. Maurer, M. Cerhan, J. Ng, W. L. King, R. Bennani, N. N. Ansell, S. Habermann, T. Witzig, T. Wang, Y. Nowakowski, G. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430099/ http://dx.doi.org/10.1097/01.HS9.0000847536.55944.b5 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Bock, A. Mwangi, R. Maurer, M. Cerhan, J. Ng, W. L. King, R. Bennani, N. N. Ansell, S. Habermann, T. Witzig, T. Wang, Y. Nowakowski, G. P1168: CHARACTERISTICS PREDICTIVE OF PROGRESSION DURING FRONTLINE TREATMENT IN AGGRESSIVE B-CELL LYMPHOMAS |
| title | P1168: CHARACTERISTICS PREDICTIVE OF PROGRESSION DURING FRONTLINE TREATMENT IN AGGRESSIVE B-CELL LYMPHOMAS |
| title_full | P1168: CHARACTERISTICS PREDICTIVE OF PROGRESSION DURING FRONTLINE TREATMENT IN AGGRESSIVE B-CELL LYMPHOMAS |
| title_fullStr | P1168: CHARACTERISTICS PREDICTIVE OF PROGRESSION DURING FRONTLINE TREATMENT IN AGGRESSIVE B-CELL LYMPHOMAS |
| title_full_unstemmed | P1168: CHARACTERISTICS PREDICTIVE OF PROGRESSION DURING FRONTLINE TREATMENT IN AGGRESSIVE B-CELL LYMPHOMAS |
| title_short | P1168: CHARACTERISTICS PREDICTIVE OF PROGRESSION DURING FRONTLINE TREATMENT IN AGGRESSIVE B-CELL LYMPHOMAS |
| title_sort | p1168: characteristics predictive of progression during frontline treatment in aggressive b-cell lymphomas |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430099/ http://dx.doi.org/10.1097/01.HS9.0000847536.55944.b5 |
| work_keys_str_mv | AT bocka p1168characteristicspredictiveofprogressionduringfrontlinetreatmentinaggressivebcelllymphomas AT mwangir p1168characteristicspredictiveofprogressionduringfrontlinetreatmentinaggressivebcelllymphomas AT maurerm p1168characteristicspredictiveofprogressionduringfrontlinetreatmentinaggressivebcelllymphomas AT cerhanj p1168characteristicspredictiveofprogressionduringfrontlinetreatmentinaggressivebcelllymphomas AT ngwl p1168characteristicspredictiveofprogressionduringfrontlinetreatmentinaggressivebcelllymphomas AT kingr p1168characteristicspredictiveofprogressionduringfrontlinetreatmentinaggressivebcelllymphomas AT bennaninn p1168characteristicspredictiveofprogressionduringfrontlinetreatmentinaggressivebcelllymphomas AT ansells p1168characteristicspredictiveofprogressionduringfrontlinetreatmentinaggressivebcelllymphomas AT habermannt p1168characteristicspredictiveofprogressionduringfrontlinetreatmentinaggressivebcelllymphomas AT witzigt p1168characteristicspredictiveofprogressionduringfrontlinetreatmentinaggressivebcelllymphomas AT wangy p1168characteristicspredictiveofprogressionduringfrontlinetreatmentinaggressivebcelllymphomas AT nowakowskig p1168characteristicspredictiveofprogressionduringfrontlinetreatmentinaggressivebcelllymphomas |